Why Supercentenarians Hold the Key to Extended Life

Supercentenarians are rare people who have reached the age of 110 and remain fit. Amazingly, many of them never get sick, despite having some bad health habits in some cases. Scientists say it all comes down to genetics — which could lead to a gene therapy that promotes longevity. Here's how super-c's will help us… » 1/03/14 11:27am 1/03/14 11:27am

Researchers remove extra chromosome from Down’s syndrome cells. Could a…

Scientists from the University of Washington have successfully removed an extra copy of chromosome 21 in cell cultures belonging to a person with Down's syndrome. While the breakthrough is unlikely to result in an outright treatment for the condition, it could pave the way for gene therapies in which many of the… » 11/12/12 3:02pm 11/12/12 3:02pm

Europe approves new drug that can fix faulty genes

The idea of treating genetic diseases by replacing a defective gene with a working copy has been around for nearly three decades, but the road to creating an actual therapy that's safe and effective has proven to be a long and difficult one. Now, thanks to the efforts of the Dutch biotech company uniQure, the Western… » 11/05/12 2:04pm 11/05/12 2:04pm

Breakthrough: Gene Therapy Provides Full Protection from HIV…

For hundreds of years, immunization has been one of society's most elegant and dependable methods of disease prevention. Vaccines have been developed for infections ranging from measles to HPV. Many of us get vaccinated to protect ourselves against seasonal illness, or before traveling internationally. Vaccination is… » 12/01/11 8:11am 12/01/11 8:11am

How the U.S. government helped fund the development of gene therapy

Over at Discover magazine, Veronique Greenwood has written a terrific article explaining the development of gene therapy, one of the most promising avenues of medical research over the last several decades. And, she explains, this basic, life-saving research couldn't have been done without the help of government… » 10/27/11 4:30pm 10/27/11 4:30pm